The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema.

No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA vs DPP4i users.

For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

CHICAGO — Tariffs, the rise of GLP-1 medications and concerns about ultra-processed foods (UPFs) remain some of the major ...

GLP-1 agonists and dual agonists can cause hypoglycemia, nausea, and more. But there are ways to lessen the side effects, so you can keep taking the medication.

Low rates of retained gastric contents were seen in endoscopy patients on GLP-1 receptor agonists ( RAs), a retrospective ...

For older patients with cancer and T2D, GLP-1 RA use is associated with lower all-cause mortality than DPP4i use.